HDAC9 and cancer: On the one hand, SCFAs can inhibit HDAC of immune cells, such as neutrophils, macrophages, T cells, or act as ligands for GPCRs, to affect the production of cytokines and induce cell differentiation, playing anti-inflammatory and anti-cancer effects.